Treatment of snoring using a non-invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial
- PMID: 35867153
- PMCID: PMC9813098
- DOI: 10.1007/s00405-022-07539-9
Treatment of snoring using a non-invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial
Erratum in
-
Correction: Treatment of snoring using a non-invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial.Eur Arch Otorhinolaryngol. 2023 Jan;280(1):313. doi: 10.1007/s00405-022-07624-z. Eur Arch Otorhinolaryngol. 2023. PMID: 36036836 Free PMC article. No abstract available.
Abstract
Objectives: The aim of this study was to assess safety and efficacy of a non-invasive 2940 nm Er:YAG treatment with SMOOTH mode in reducing snoring in adult patients and to compare its efficacy and safety to sham treatment in a randomized controlled trial setting. METHODS: 40 primary snoring patients (≥ 18 year, AHI < 15e/h, BMI ≤ 30) were randomized to receive either 3 sessions NightLase or sham laser treatment. The main outcome measures were Snore Outcomes Survey (SOS), the Spouse/Bed Partner Survey (SBPS), a visual analogue snoring scale (bed partner) and a visual analogue pain scale.
Results: NightLase was well tolerated, no local anaesthesia was required (mean VAS pain score in NightLase group = 3.0 ± 1.7). No complications occurred. SOS, SBPS and VAS snoring scores improved in the NightLase group (33.7 ± 14.1 to 56.2 ± 16.1) (35.0 ± 17.1 to 61.5 ± 16.4) and (7.9 ± 2.0 to 4.7 ± 2.8) while no changing in the sham group (32.2 ± 14.5 vs 32.1 ± 13.0) (36.7 ± 12.1 vs 34.7 ± 12.7) (8.1 ± 1.7 vs 8.0 ± 1.6), respectively.
Conclusions: NightLase is a safe, minimal invasive treatment that significantly reduced snoring compared to sham treatment.
Keywords: NightLase; OSA; Snoring; UARS.
© 2022. The Author(s).
Conflict of interest statement
The authors have no conflict of interest to declare. There are no competing financial interests in relation to the work described.
Figures
Comment in
-
Sleep surgery randomized clinical trials: design and execution are important.Eur Arch Otorhinolaryngol. 2023 Apr;280(4):2057-2058. doi: 10.1007/s00405-022-07636-9. Epub 2022 Sep 6. Eur Arch Otorhinolaryngol. 2023. PMID: 36068324 No abstract available.
References
-
- Lee CYS, Lee CCY. Evaluation of a non-ablative Er: YAG laser procedure to increase the oropharyngeal airway volume: a pilot study. Dental Oral Craniofacial Res. 2015;1(3):56–59.
-
- Fini Storchi I, Parker S, Bovis F, Benedicenti S, Amaroli A. Outpatient erbium:YAG (2940 nm) laser treatment for snoring: a prospective study on 40 patients [published correction appears in Lasers Med Sci. 2019 Mar;34(2):431] Lasers Med Sci. 2018;33(2):399–406. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
